Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bolt Biotherapeutics (BOLT) Interest & Investment Income (2020 - 2025)

Bolt Biotherapeutics' Interest & Investment Income history spans 6 years, with the latest figure at $477000.0 for Q3 2025.

  • For Q3 2025, Interest & Investment Income fell 62.35% year-over-year to $477000.0; the TTM value through Sep 2025 reached $3.1 million, down 49.35%, while the annual FY2024 figure was $5.3 million, 24.92% down from the prior year.
  • Interest & Investment Income for Q3 2025 was $477000.0 at Bolt Biotherapeutics, down from $599000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $1.9 million in Q3 2023 and bottomed at -$82000.0 in Q4 2021.
  • The 5-year median for Interest & Investment Income is $980000.0 (2024), against an average of $888789.5.
  • The largest annual shift saw Interest & Investment Income plummeted 783.33% in 2021 before it soared 1371.95% in 2022.
  • A 5-year view of Interest & Investment Income shows it stood at -$82000.0 in 2021, then skyrocketed by 1371.95% to $1.0 million in 2022, then surged by 78.62% to $1.9 million in 2023, then crashed by 47.4% to $980000.0 in 2024, then plummeted by 51.33% to $477000.0 in 2025.
  • Per Business Quant, the three most recent readings for BOLT's Interest & Investment Income are $477000.0 (Q3 2025), $599000.0 (Q2 2025), and $1.1 million (Q1 2025).